Individualized PsA Treatment With an IL-23i or a JAKi

Opublikowano: 2026-11-02

Individualized PsA Treatment With an IL-23i or a JAKi In Part 2 of our series on managing the complexities of PsA, Saakshi Khattri, MD, and Lindsay Tom, PA-C, discuss their experience individualizing treatment for real patients with multidomain PsA and the IL-23i and JAKi data that informed their decisions. Sponsored by AbbVie Medical Affairs + Health Impact. https://rheumnow.com/therapeutic-update/individualized-psa-treatment-il-23i-and-jaki After posting, if you could log into spodity studio, and turn off transcripts, comments, and chapters, that would be great. If you don't have time to do this, let me know and I can log...